Literature DB >> 16081641

Transforming growth factor beta-activated kinase 1 is a key mediator of ovine follicle-stimulating hormone beta-subunit expression.

Nedal Safwat1, Jun Ninomiya-Tsuji, A Jesse Gore, William L Miller.   

Abstract

FSH, a key regulator of gonadal function, contains a beta-subunit (FSHbeta) that is transcriptionally induced by activin, a member of the TGFbeta-superfamily. This study used 4.7 kb of the ovine FSHbeta-promoter linked to luciferase (oFSHbetaLuc) plus a well-characterized activin-responsive construct, p3TPLuc, to investigate the hypothesis that Smad3, TGFbeta-activated kinase 1 (TAK1), or both cause activin-mediated induction of FSH. Overexpression of either Smad3 or TAK1 induced oFSHbetaLuc in gonadotrope-derived LbetaT2 cells as much as activin itself. Induction of p3TPLuc by activin is known to require Smad3 activation in many cell types, and this was true in LbetaT2 cells, where 10-fold induction by activin (2-8 h after activin treatment) was blocked more than 90% by two dominant negative (DN) inhibitors of Smad3 [DN-Smad3 (3SA) and DN-Smad3 (D407E)]. By contrast, 6.5-fold induction of oFSHbetaLuc by activin (10-24 h after activin treatment) was not blocked by either DN-Smad inhibitor, suggesting that activation of Smad3 did not trigger induction of oFSHbetaLuc. By contrast, inhibition of TAK1 by a DN-TAK1 construct led to a 50% decrease in activin-mediated induction of oFSHbetaLuc, and a specific inhibitor of TAK1 (5Z-7-Oxozeanol) blocked induction by 100%, indicating that TAK1 is necessary for activin induction of oFSHbetaLuc. Finally, inhibiting p38-MAPK (often activated by TAK1) blocked induction of oFSHbetaLuc by 60%. In conclusion, the data presented here indicate that activation of TAK1 (and probably p38-MAPK), but not Smad3, is necessary for triggering induction of oFSHbeta by activin.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16081641      PMCID: PMC1698747          DOI: 10.1210/en.2005-0457

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  64 in total

1.  p38 MAPK is involved in activin A- and hepatocyte growth factor-mediated expression of pro-endocrine gene neurogenin 3 in AR42J-B13 cells.

Authors:  Takeshi Ogihara; Hirotaka Watada; Rei Kanno; Fuki Ikeda; Takashi Nomiyama; Yasushi Tanaka; Atsuhito Nakao; Michael S German; Itaru Kojima; Ryuzo Kawamori
Journal:  J Biol Chem       Date:  2003-04-01       Impact factor: 5.157

2.  Activin signal transduction in the fetal rat adrenal gland and in human H295R cells.

Authors:  E Y Wang; E Y Ma; T K Woodruff
Journal:  J Endocrinol       Date:  2003-07       Impact factor: 4.286

3.  A dominant negative TAK1 inhibits cellular fibrotic responses induced by TGF-beta.

Authors:  Koichiro Ono; Toshihiko Ohtomo; Jun Ninomiya-Tsuji; Masayuki Tsuchiya
Journal:  Biochem Biophys Res Commun       Date:  2003-07-25       Impact factor: 3.575

4.  TAB3, a new binding partner of the protein kinase TAK1.

Authors:  Peter C F Cheung; Angel R Nebreda; Philip Cohen
Journal:  Biochem J       Date:  2004-02-15       Impact factor: 3.857

5.  HER2/Neu- and TAK1-mediated up-regulation of the transforming growth factor beta inhibitor Smad7 via the ETS protein ER81.

Authors:  Sean C Dowdy; Andrea Mariani; Ralf Janknecht
Journal:  J Biol Chem       Date:  2003-08-28       Impact factor: 5.157

6.  Identification of a human NF-kappaB-activating protein, TAB3.

Authors:  Ge Jin; Alison Klika; Michelle Callahan; Ben Faga; Joel Danzig; Zhengfan Jiang; Xiaoxia Li; George R Stark; John Harrington; Bruce Sherf
Journal:  Proc Natl Acad Sci U S A       Date:  2004-02-06       Impact factor: 11.205

7.  Activin regulation of the follicle-stimulating hormone beta-subunit gene involves Smads and the TALE homeodomain proteins Pbx1 and Prep1.

Authors:  Janice S Bailey; Naama Rave-Harel; Shauna M McGillivray; Djurdjica Coss; Pamela L Mellon
Journal:  Mol Endocrinol       Date:  2004-02-05

8.  Role of the TAB2-related protein TAB3 in IL-1 and TNF signaling.

Authors:  Tohru Ishitani; Giichi Takaesu; Jun Ninomiya-Tsuji; Hiroshi Shibuya; Richard B Gaynor; Kunihiro Matsumoto
Journal:  EMBO J       Date:  2003-12-01       Impact factor: 11.598

9.  Smads 2 and 3 are differentially activated by transforming growth factor-beta (TGF-beta ) in quiescent and activated hepatic stellate cells. Constitutive nuclear localization of Smads in activated cells is TGF-beta-independent.

Authors:  Chenghai Liu; Marianna D A Gaça; E Scott Swenson; Vincent F Vellucci; Michael Reiss; Rebecca G Wells
Journal:  J Biol Chem       Date:  2003-01-22       Impact factor: 5.157

Review 10.  TGF-beta signal transduction.

Authors:  J Massagué
Journal:  Annu Rev Biochem       Date:  1998       Impact factor: 23.643

View more
  18 in total

Review 1.  A FoxL in the Smad house: activin regulation of FSH.

Authors:  Djurdjica Coss; Pamela L Mellon; Varykina G Thackray
Journal:  Trends Endocrinol Metab       Date:  2010-07-02       Impact factor: 12.015

Review 2.  Molecular regulation of follicle-stimulating hormone synthesis, secretion and action.

Authors:  Nandana Das; T Rajendra Kumar
Journal:  J Mol Endocrinol       Date:  2018-02-07       Impact factor: 5.098

3.  FOXL2 is involved in the synergy between activin and progestins on the follicle-stimulating hormone β-subunit promoter.

Authors:  Yasmin Ghochani; Jasjit K Saini; Pamela L Mellon; Varykina G Thackray
Journal:  Endocrinology       Date:  2012-01-31       Impact factor: 4.736

4.  SMADs and FOXL2 synergistically regulate murine FSHbeta transcription via a conserved proximal promoter element.

Authors:  Stella Tran; Pankaj Lamba; Ying Wang; Daniel J Bernard
Journal:  Mol Endocrinol       Date:  2011-05-26

5.  p38 mitogen-activated protein kinase is critical for synergistic induction of the FSH(beta) gene by gonadotropin-releasing hormone and activin through augmentation of c-Fos induction and Smad phosphorylation.

Authors:  Djurdjica Coss; Cameron M Hand; Karen K J Yaphockun; Heather A Ely; Pamela L Mellon
Journal:  Mol Endocrinol       Date:  2007-09-06

6.  Synergistic induction of follicle-stimulating hormone beta-subunit gene expression by gonadal steroid hormone receptors and Smad proteins.

Authors:  Varykina G Thackray; Pamela L Mellon
Journal:  Endocrinology       Date:  2007-12-13       Impact factor: 4.736

7.  Paired-like homeodomain transcription factors 1 and 2 regulate follicle-stimulating hormone beta-subunit transcription through a conserved cis-element.

Authors:  Pankaj Lamba; Vishal Khivansara; Ana C D'Alessio; Michelle M Santos; Daniel J Bernard
Journal:  Endocrinology       Date:  2008-03-13       Impact factor: 4.736

8.  Normal gonadotropin production and fertility in gonadotrope-specific Bmpr1a knockout mice.

Authors:  Xiang Zhou; Ying Wang; Luisina Ongaro; Ulrich Boehm; Vesa Kaartinen; Yuji Mishina; Daniel J Bernard
Journal:  J Endocrinol       Date:  2016-03-30       Impact factor: 4.286

9.  TAK1 is required for survival of mouse fibroblasts treated with TRAIL, and does so by NF-kappaB dependent induction of cFLIPL.

Authors:  Josep Maria Lluis; Ulrich Nachbur; Wendy Diane Cook; Ian Edward Gentle; Donia Moujalled; Maryline Moulin; Wendy Wei-Lynn Wong; Nufail Khan; Diep Chau; Bernard Andrew Callus; James Edward Vince; John Silke; David Lawrence Vaux
Journal:  PLoS One       Date:  2010-01-08       Impact factor: 3.240

10.  Activin A induces ovine follicle stimulating hormone beta using -169/-58 bp of its promoter and a simple TATA box.

Authors:  Sang-oh Han; William L Miller
Journal:  Reprod Biol Endocrinol       Date:  2009-06-24       Impact factor: 5.211

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.